Some opportunities for immunotherapy in coronavirus infection
Here we review means of immunomodulatory therapy for coronavirus infection caused by SARS-CoV-2 (COVID-19). It has been appreciated that highly limited arsenal of relatively effective means and methods of prevention and treatment of the COVID-19 pandemic is available. The goal of our study was to an...
Guardado en:
Autores principales: | V. S. Smirnov, Areg A. Totolian |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/54c9f36d33bd4b29beb0e3e5c4c777a2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Innate immunity in coronavirus infection
por: V. S. Smirnov, et al.
Publicado: (2020) -
History of investigation and current classification of coronaviruses (<i>Nidovirales: Coronaviridae</i>)
por: M. Yu. Shchelkanov, et al.
Publicado: (2020) -
Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
por: Li Wenyuan, et al.
Publicado: (2021) -
Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis
por: Vineet D. Menachery, et al.
Publicado: (2017) -
Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini M, et al.
Publicado: (2021)